BIO-TECHNE Corp

TECHNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$1.2B

▼ 0.4% YoY

Net Income

$181.9M

▲ 147.8% YoY

EPS

$1.16

▲ 152.2% YoY

Cash

$264.7M

▲ 63.2% YoY

FY 2026 · As of 2026-06-30

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.